Yukimasa Hisada

768 total citations
18 papers, 596 citations indexed

About

Yukimasa Hisada is a scholar working on Nephrology, Molecular Biology and Rheumatology. According to data from OpenAlex, Yukimasa Hisada has authored 18 papers receiving a total of 596 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Nephrology, 5 papers in Molecular Biology and 5 papers in Rheumatology. Recurrent topics in Yukimasa Hisada's work include Renal Diseases and Glomerulopathies (6 papers), Cell Adhesion Molecules Research (5 papers) and Systemic Lupus Erythematosus Research (5 papers). Yukimasa Hisada is often cited by papers focused on Renal Diseases and Glomerulopathies (6 papers), Cell Adhesion Molecules Research (5 papers) and Systemic Lupus Erythematosus Research (5 papers). Yukimasa Hisada collaborates with scholars based in Japan and United States. Yukimasa Hisada's co-authors include Satoshi Ohta, Kengo Furuichi, Hitoshi Yokoyama, K. Kobayashi, Naofumi Mukaida, Kouji Matsushima, Chikako Segawa, Takashi Wada, Kazuya Takasawa and Kenichi Kobayashi and has published in prestigious journals such as Kidney International, American Journal of Kidney Diseases and Nephrology Dialysis Transplantation.

In The Last Decade

Yukimasa Hisada

18 papers receiving 583 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yukimasa Hisada Japan 10 234 223 203 122 96 18 596
Chikako Segawa Japan 6 176 0.8× 152 0.7× 194 1.0× 112 0.9× 35 0.4× 10 422
Norihisa Akano Japan 14 171 0.7× 332 1.5× 92 0.5× 39 0.3× 117 1.2× 26 627
Allen R. Hendricks United States 8 446 1.9× 239 1.1× 600 3.0× 79 0.6× 129 1.3× 16 913
Dawn J. Caster United States 13 241 1.0× 309 1.4× 432 2.1× 50 0.4× 102 1.1× 33 694
Jan-Hendrik Riedel Germany 9 500 2.1× 152 0.7× 114 0.6× 87 0.7× 71 0.7× 13 661
Trageen Baumgart United States 7 359 1.5× 158 0.7× 86 0.4× 85 0.7× 108 1.1× 9 641
G Pannarale Italy 10 104 0.4× 156 0.7× 117 0.6× 39 0.3× 179 1.9× 15 504
Benoît Manfroi France 9 358 1.5× 117 0.5× 125 0.6× 118 1.0× 134 1.4× 13 575
Elizabeth Papalardo United States 13 322 1.4× 102 0.5× 740 3.6× 36 0.3× 101 1.1× 19 944
Andreas Perniok Germany 11 260 1.1× 59 0.3× 233 1.1× 42 0.3× 105 1.1× 15 478

Countries citing papers authored by Yukimasa Hisada

Since Specialization
Citations

This map shows the geographic impact of Yukimasa Hisada's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yukimasa Hisada with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yukimasa Hisada more than expected).

Fields of papers citing papers by Yukimasa Hisada

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yukimasa Hisada. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yukimasa Hisada. The network helps show where Yukimasa Hisada may publish in the future.

Co-authorship network of co-authors of Yukimasa Hisada

This figure shows the co-authorship network connecting the top 25 collaborators of Yukimasa Hisada. A scholar is included among the top collaborators of Yukimasa Hisada based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yukimasa Hisada. Yukimasa Hisada is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Hara, Akinori, Miho Shimizu, Hirokazu Kakuda, et al.. (2020). Propagermanium administration for patients with type 2 diabetes and nephropathy: A randomized pilot trial. Endocrinology Diabetes & Metabolism. 3(3). e00159–e00159. 6 indexed citations
2.
Hisada, Yukimasa, et al.. (2013). [A review of urinary examination--what medical practice expects now and what urinary examinations have to provide in the future].. PubMed. 61(7). 622–8. 2 indexed citations
3.
Furuichi, Kengo, Yukimasa Hisada, Miho Shimizu, et al.. (2011). Matrix metalloproteinase-2 (MMP-2) and membrane-type 1 MMP (MT1-MMP) affect the remodeling of glomerulosclerosis in diabetic OLETF rats. Nephrology Dialysis Transplantation. 26(10). 3124–3131. 22 indexed citations
4.
Hisada, Yukimasa, et al.. (2011). [Pitfalls in measuring urinary proteins: age-related changes in urinary creatinine excretion that affect the urine protein/creatinine ratio].. PubMed. 59(2). 172–8. 2 indexed citations
5.
Yokoyama, Hitoshi, Miho Shimizu, Takashi Wada, et al.. (2002). The Beneficial Effects of Lymphocytapheresis for Treatment of Nephrotic Syndrome. Therapeutic Apheresis. 6(2). 167–173. 5 indexed citations
6.
Wada, Takashi, Kengo Furuichi, Norihiko Sakai, et al.. (2001). Involvement of p38 mitogen-activated protein kinase followed by chemokine expression in crescentic glomerulonephritis. American Journal of Kidney Diseases. 38(6). 1169–1177. 42 indexed citations
7.
Iwata, Yasunori, Norihiko Sakai, Miho Shimizu, et al.. (2001). [Effect of interferon therapy on hepatitis B virus related membranous nephropathy associated with focal segmental glomerulosclerosis].. PubMed. 43(2). 76–81. 1 indexed citations
8.
Yokoo, Takashi, Yasunori Utsunomiya, Tadao Kawamura, et al.. (2000). Anti-GBM glomerulonephritis in mice lacking IL-1β-converting enzyme (ICE). Clinical and Experimental Nephrology. 4(2). 114–118. 2 indexed citations
9.
Yokoo, Takashi, Toya Ohashi, Yasunori Utsunomiya, et al.. (1999). Prophylaxis of Antibody-Induced Acute Glomerulonephritis with Genetically Modified Bone Marrow-Derived Vehicle Cells. Human Gene Therapy. 10(16). 2673–2678. 33 indexed citations
10.
Ohta, Satoshi, Hitoshi Yokoyama, Takashi Wada, et al.. (1999). Exacerbation of glomerulonephritis in subjects with chronic hepatitis C virus infection after interferon therapy. American Journal of Kidney Diseases. 33(6). 1040–1048. 45 indexed citations
11.
Segawa, Chikako, Takashi Wada, Kengo Furuichi, et al.. (1997). In situ expression and soluble form of P-selectin in human glomerulonephritis. Kidney International. 52(4). 1054–1063. 45 indexed citations
12.
Yokoyama, Hitoshi, Takashi Wada, Satoshi Ohta, et al.. (1997). Glomerular ICAM-1 Expression Related to Circulating TNF-α in Human Glomerulonephritis. Nephron. 76(4). 425–433. 39 indexed citations
13.
Ohta, Satoshi, Hitoshi Yokoyama, Kengo Furuichi, et al.. (1997). Clinicopathologic features of glomerular lesions associated with hepatitis C virus infection in Japan. Clinical and Experimental Nephrology. 1(3). 216–224. 5 indexed citations
14.
Wada, Takashi, Hitoshi Yokoyama, Shaobo Su, et al.. (1996). Monitoring urinary levels of monocyte chemotactic and activating factor reflects disease activity of lupus nephritis. Kidney International. 49(3). 761–767. 173 indexed citations
15.
Ohta, Satoshi, H. Yokoyama, Yukimasa Hisada, et al.. (1994). [A case of ANCA-associated rapidly progressive glomerulonephritis with oral aphtha and erythema nodosum].. PubMed. 36(10). 1184–90. 3 indexed citations
16.
Yokoyama, Hitoshi, Yukimasa Hisada, Satoshi Ohta, et al.. (1994). Risk Factors for Infection and Immunoglobulin Replacement Therapy in Adult Nephrotic Syndrome. American Journal of Kidney Diseases. 24(3). 427–436. 62 indexed citations
17.
Terada, Tadashi, Kouichi Hirata, Yukimasa Hisada, Yoshinobu Hoshii, & Yasuni Nakanuma. (1994). Obstructive jaundice caused by the deposition of amyloid‐like substances in the extrahepatic and large intrahepatic bile ducts in a patient with multiple myeloma. Histopathology. 24(5). 485–487. 12 indexed citations
18.
Yokoyama, Hitoshi, Naohisa Tomosugi, Yukimasa Hisada, et al.. (1994). Detection of urinary interleukin-8 in glomerular diseases. Kidney International. 46(2). 455–460. 97 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Chikako Segawa Breakdown of academic impact, for papers by Norihisa Akano Breakdown of academic impact, for papers by Allen R. Hendricks Breakdown of academic impact, for papers by Dawn J. Caster Breakdown of academic impact, for papers by Jan-Hendrik Riedel Breakdown of academic impact, for papers by Trageen Baumgart Breakdown of academic impact, for papers by G Pannarale Breakdown of academic impact, for papers by Benoît Manfroi Breakdown of academic impact, for papers by Elizabeth Papalardo Breakdown of academic impact, for papers by Andreas Perniok
Rankless by CCL
2026